Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| COMBINATORX, INC | 12,935,885 | reported | 17 Oct 2011 | tx 3−357,944 |
| TERCICA INC | 7,062,494 | reported | 22 Mar 2004 | tx 5+7,057,497−6,387,497 |
| VIACELL INC | 4,939,852 | reported | 19 Jan 2006 | tx 3+125,000−238,637 |
| MPM ACQUISITION CORP | 3,887,502 | reported | 27 Sept 2016 | tx 18+7,240,807−7,946,271 |
| HEMOSENSE INC | 3,828,319 | reported | 13 Sept 2007 | tx 2−475,400 |
| Harpoon Therapeutics, Inc. | 3,220,844 | reported | 15 Apr 2021 | tx 36+4,673,652−4,851,371 |
| iTeos Therapeutics, Inc. | 2,935,301 | reported | 02 Dec 2021 | tx 25−315,319 |
| Epizyme, Inc. | 2,880,485 | reported | 05 Jun 2013 | tx 4+2,702,154−8,106,472 |
| BARRIER THERAPEUTICS INC | 2,341,024 | reported | 04 May 2004 | tx 3+2,341,024−4,282,050 |
| TURMERIC ACQUISITION CORP. | 2,298,750 | reported | 30 Apr 2021 | tx 2+433,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | SALE | Werewolf Therapeutics, Inc. | 80,852 | 0.48 USD | 10b5-1 |
| 28 May 2026 | SALE | Werewolf Therapeutics, Inc. | 27,698 | 0.46 USD | 10b5-1 |
| 29 May 2026 | SALE | Werewolf Therapeutics, Inc. | 32,556 | 0.45 USD | 10b5-1 |
| 21 May 2026 | SALE | Werewolf Therapeutics, Inc. | 36,387 | 0.42 USD | 10b5-1 |
| 22 May 2026 | SALE | Werewolf Therapeutics, Inc. | 87,425 | 0.45 USD | 10b5-1 |
| 26 May 2026 | SALE | Werewolf Therapeutics, Inc. | 67,950 | 0.47 USD | 10b5-1 |
| 18 May 2026 | SALE | Werewolf Therapeutics, Inc. | 22,184 | 0.50 USD | 10b5-1 |
| 19 May 2026 | SALE | Werewolf Therapeutics, Inc. | 62,970 | 0.45 USD | 10b5-1 |
| 20 May 2026 | SALE | Werewolf Therapeutics, Inc. | 85,895 | 0.43 USD | 10b5-1 |
| 13 May 2026 | SALE | Werewolf Therapeutics, Inc. | 44,679 | 0.54 USD | 10b5-1 |
| 08 May 2026 | SALE | Werewolf Therapeutics, Inc. | 305,741 | 0.70 USD | 10b5-1 |
| 11 May 2026 | SALE | Werewolf Therapeutics, Inc. | 33,948 | 0.67 USD | 10b5-1 |
| 12 May 2026 | SALE | Werewolf Therapeutics, Inc. | 67,885 | 0.64 USD | 10b5-1 |
| 05 May 2026 | SALE | Werewolf Therapeutics, Inc. | 6,860 | 0.69 USD | 10b5-1 |
| 06 May 2026 | SALE | Werewolf Therapeutics, Inc. | 14,635 | 0.66 USD | 10b5-1 |
| 07 May 2026 | SALE | Werewolf Therapeutics, Inc. | 79,086 | 0.63 USD | 10b5-1 |
| 30 Apr 2026 | SALE | Werewolf Therapeutics, Inc. | 168,262 | 0.72 USD | 10b5-1 |
| 01 May 2026 | SALE | Werewolf Therapeutics, Inc. | 58,394 | 0.73 USD | 10b5-1 |
| 04 May 2026 | SALE | Werewolf Therapeutics, Inc. | 47,963 | 0.72 USD | 10b5-1 |
| 27 Apr 2026 | SALE | Werewolf Therapeutics, Inc. | 53,940 | 0.85 USD | 10b5-1 |
| 28 Apr 2026 | SALE | Werewolf Therapeutics, Inc. | 95,412 | 0.73 USD | 10b5-1 |
| 29 Apr 2026 | SALE | Werewolf Therapeutics, Inc. | 56,559 | 0.69 USD | 10b5-1 |
| 16 Jan 2026 | SALE | Werewolf Therapeutics, Inc. | 38,782 | 0.54 USD | |
| 13 Jan 2026 | SALE | Werewolf Therapeutics, Inc. | 43,198 | 0.55 USD | |
| 15 Jan 2026 | SALE | Werewolf Therapeutics, Inc. | 37,413 | 0.55 USD |
5 purchases reported after at least 12 months of silence — most recent on 23 Jun 2020.